Microarray analysis of gene expression by skeletal muscle of three mouse models of Kennedy disease/spinal bulbar muscular atrophy

PLoS ONE

Volumn 5, Issue 9, 2010, Pages

  Mo, Kaiguo ^a   Razak, Zak ^a   Rao, Pengcheng ^a   Yu, Zhigang ^b   Adachi, Hiroaki ^c   Katsuno, Masahisa ^c,d   Sobue, Gen ^c   Lieberman, Andrew P ^b   Timothy Westwood, J ^a   Ashley Monks, D ^a,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DNA MICROARRAY; ENERGY BALANCE; FEMALE; GENE EXPRESSION; GENOTYPE; HINDLIMB; KENNEDY DISEASE; MALE; MICROARRAY ANALYSIS; MOUSE; MUSCLE ATROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; SKELETAL MUSCLE; WILD TYPE; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; SPINAL MUSCULAR ATROPHY; TRANSGENIC MOUSE;

ANIMALIA; MUS; MUS MUSCULUS;

ANIMALS; BULBO-SPINAL ATROPHY, X-LINKED; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUSCULAR ATROPHY, SPINAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 77958530066     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012922     Document Type: Article

References (62)

1. Kennedy WR, Alter M, Sung JH (1968) Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 18: 671-680.
2. Atsuta N, Watanabe H, Ito M, Banno H, Suzuki K, et al. (2006) Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain 129: 1446-1455.
3. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352: 77-79.
4. Zoghbi HY, Orr HT (2000) Glutamine repeats and neurodegeneration. Annu Rev Neurosci 23: 217-247.
5. Monks DA, Rao P, Mo K, Johansen JA, Lewis G, et al. (2008) Androgen receptor and Kennedy disease/spinal bulbar muscular atrophy. Horm Behav 53: 729-740.
6. Yu Z, Dadgar N, Albertelli M, Gruis K, Jordan C, et al. (2006) Androgendependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Invest 116: 2663-2672.
7. Monks DA, Johansen JA, Mo K, Rao P, Eagleson B, et al. (2007) Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine expansion. Proc Natl Acad Sci U S A 104: 18259-18264.
8. Katsuno M, Adachi H, Waza M, Banno H, Suzuki K, et al. (2006) Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA). Exp Neurol 200: 8-18.
9. Sopher BL, Thomas PS, Jr., LaFevre-Bernt MA, Holm IE, Wilke SA, et al. (2004) Androgen Receptor YAC Transgenic Mice Recapitulate SBMA Motor Neuronopathy and Implicate VEGF164 in the Motor Neuron Degeneration. Neuron 41: 687-699.
10. Katsuno M, Adachi H, Sobue G (2003) Spinal and Bulbar Muscular Atrophy: Clinical Features and Pathogenesis. ACNR 3: 8-12.
11. Adachi H, Waza M, Katsuno M, Tanaka F, Doyu M, et al. (2007) Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy. Neuropathol Appl Neurobiol 33: 135-151.
12. Thomas PS, Jr., Fraley GS, Damian V, Woodke LB, Zapata F, et al. (2006) Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy. Hum Mol Genet 15: 2225-2238.
13. McCampbell A, Taylor JP, Taye AA, Robitschek J, Li M, et al. (2000) CREBbinding protein sequestration by expanded polyglutamine. Hum Mol Genet 9: 2197-2202.
14. Lieberman AP, Harmison G, Strand AD, Olson JM, Fischbeck KH (2002) Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor. Hum Mol Genet 11: 1967-1976.
15. Sacheck JM, Hyatt JP, Raffaello A, Jagoe RT, Roy RR, et al. (2007) Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J 21: 140-155.
16. Minamiyama M, Katsuno M, Adachi H, Waza M, Sang C, et al. (2004) Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet.
17. Stenoien DL, Cummings CJ, Adams HP, Mancini MG, Patel K, et al. (1999) Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum Mol Genet 8: 731-741.
18. Walcott JL, Merry DE (2002) Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy. J Biol Chem 277: 50855-50859.
19. Kobayashi Y, Kume A, Li M, Doyu M, Hata M, et al. (2000) Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract. J Biol Chem 275: 8772-8778.
20. Bailey CK, Andriola IF, Kampinga HH, Merry DE (2002) Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy. Hum Mol Genet 11: 515-523.
21. Ishihara K, Yamagishi N, Saito Y, Adachi H, Kobayashi Y, et al. (2003) Hsp105alpha suppresses the aggregation of truncated androgen receptor with expanded CAG repeats and cell toxicity. J Biol Chem 278: 25143-25150.
22. Thomas M, Harrell JM, Morishima Y, Peng HM, Pratt WB, et al. (2006) Pharmacologic and genetic inhibition of hsp90-dependent trafficking reduces aggregation and promotes degradation of the expanded glutamine androgen receptor without stress protein induction. Hum Mol Genet 15: 1876-1883.
23. Katsuno M, Sang C, Adachi H, Minamiyama M, Waza M, et al. (2005) Pharmacological induction of heat-shock proteins alleviates polyglutaminemediated motor neuron disease. Proc Natl Acad Sci U S A 102: 16801-16806.
24. Waza M, Adachi H, Katsuno M, Minamiyama M, Sang C, et al. (2005) 17- AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat Med 11: 1088-1095.
25. Ranganathan S, Harmison GG, Meyertholen K, Pennuto M, Burnett BG, et al. (2009) Mitochondrial abnormalities in spinal and bulbar muscular atrophy. Hum Mol Genet 18: 27-42.
26. MacLean HE, Chiu WS, Notini AJ, Axell AM, Davey RA, et al. (2008) Impaired skeletal muscle development and function in male, but not female, genomic androgen receptor knockout mice. FASEB J 22: 2676-2689.
27. Yoshioka M, Boivin A, Bolduc C, St-Amand J (2007) Gender difference of androgen actions on skeletal muscle transcriptome. J Mol Endocrinol 39: 119-133.
28. Yoshioka M, Boivin A, Ye P, Labrie F, St-Amand J (2006) Effects of dihydrotestosterone on skeletal muscle transcriptome in mice measured by serial analysis of gene expression. J Mol Endocrinol 36: 247-259.
29. Strand AD, Aragaki AK, Shaw D, Bird T, Holton J, et al. (2005) Gene expression in Huntington's disease skeletal muscle: a potential biomarker. Hum Mol Genet 14: 1863-1876.
30. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, et al. (2004) Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. Faseb J 18: 39-51.
31. Miyazaki M, Esser KA (2009) REDD2 is enriched in skeletal muscle and inhibits mTOR signaling in response to leucine and stretch. Am J Physiol Cell Physiol 296: C583-592.
32. Pisani DF, Leclerc L, Jarretou G, Marini JF, Dechesne CA (2005) SMHS1 is involved in oxidative/glycolytic-energy metabolism balance of muscle fibers. Biochem Biophys Res Commun 326: 788-793.
33. Eigenthaler M, Engelhardt S, Schinke B, Kobsar A, Schmitteckert E, et al. (2003) Disruption of cardiac Ena-VASP protein localization in intercalated disks causes dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 285: H2471-2481.
34. Li J, Rao H, Burkin D, Kaufman SJ, Wu C (2003) The muscle integrin binding protein (MIBP) interacts with alpha7beta1 integrin and regulates cell adhesion and laminin matrix deposition. Dev Biol 261: 209-219.
35. Li J, Mayne R, Wu C (1999) A novel muscle-specific beta 1 integrin binding protein (MIBP) that modulates myogenic differentiation. J Cell Biol 147: 1391-1398.
36. Wootton PT, Flavell DM, Montgomery HE, World M, Humphries SE, et al. (2007) Lipoprotein-associated phospholipase A2 A379V variant is associated with body composition changes in response to exercise training. Nutr Metab Cardiovasc Dis 17: 24-31.
37. Fernando SM, Rao P, Niel L, Chatterjee D, Stagljar M, et al. (2010) Myocyte androgen receptors increase metabolic rate and improve body composition by reducing fat mass. Endocrinology 151: 3125-3132.
38. Orngreen MC, Schelhaas HJ, Jeppesen TD, Akman HO, Wevers RA, et al. (2008) Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency? Neurology 70: 1876-1882.
39. Wuyts W, Reyniers E, Ceuterick C, Storm K, de Barsy T, et al. (2005) Myopathy and phosphorylase kinase deficiency caused by a mutation in the PHKA1 gene. Am J Med Genet A 133A: 82-84.
40. Palazzolo I, Burnett BG, Young JE, Brenne PL, La Spada AR, et al. (2007) Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. Hum Mol Genet 16: 1593-1603.
41. Monks DA, Johansen JA, Mo K, Rao P, Eagleson B, et al. (2007) Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc Natl Acad Sci U S A 104: 18259-18264.
42. Chuang JZ, Zhou H, Zhu M, Li SH, Li XJ, et al. (2002) Characterization of a brain-enriched chaperone, MRJ, that inhibits Huntingtin aggregation and toxicity independently. J Biol Chem 277: 19831-19838.
43. Fayazi Z, Ghosh S, Marion S, Bao X, Shero M, et al. (2006) A Drosophila ortholog of the human MRJ modulates polyglutamine toxicity and aggregation. Neurobiol Dis 24: 226-244.
44. Katsuno M, Adachi H, Minamiyama M, Waza M, Doi H, et al. Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy. J Neurosci 30: 5702-5712.
45. Ribchester RR, Thomson D, Wood NI, Hinks T, Gillingwater TH, et al. (2004) Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation. Eur J Neurosci 20: 3092-3114.
46. Boirie Y, Short KR, Ahlman B, Charlton M, Nair KS (2001) Tissue-specific regulation of mitochondrial and cytoplasmic protein synthesis rates by insulin. Diabetes 50: 2652-2658.
47. Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS (2003) Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci U S A 100: 7996-8001.
48. Tong JF, Yan X, Zhu MJ, Du M (2009) AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/ Akt signaling in C2C12 myotubes. J Cell Biochem 108: 458-468.
49. Pires-Oliveira M, Maragno AL, Parreiras-e-Silva LT, Chiavegatti T, Gomes MD, et al. Testosterone represses ubiquitin ligases atrogin-1 and Murf-1 expression in an androgen-sensitive rat skeletal muscle in vivo. J Appl Physiol 108: 266-273.
50. Thomas M, Yu Z, Dadgar N, Varambally S, Yu J, et al. (2005) The unfolded protein response modulates toxicity of the expanded glutamine androgen receptor. J Biol Chem 280: 21264-21271.
51. Merry DE, Kobayashi Y, Bailey CK, Taye AA, Fischbeck KH (1998) Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy. Hum Mol Genet 7: 693-701.
52. Li M, Chevalier-Larsen ES, Merry DE, Diamond MI (2007) Soluble androgen receptor oligomers underlie pathology in a mouse model of spinobulbar muscular atrophy. J Biol Chem 282: 3157-3164.
53. Mandrusiak LM, Beitel LK, Wang X, Scanlon TC, Chevalier-Larsen E, et al. (2003) Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor. Hum Mol Genet 12: 1497-1506.
54. Adachi H, Katsuno M, Minamiyama M, Sang C, Pagoulatos G, et al. (2003) Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein. J Neurosci 23: 2203-2211.
55. Wyttenbach A, Carmichael J, Swartz J, Furlong RA, Narain Y, et al. (2000) Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease. Proc Natl Acad Sci U S A 97: 2898-2903.
56. Adachi H, Waza M, Tokui K, Katsuno M, Minamiyama M, et al. (2007) CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model. J Neurosci 27: 5115-5126.
57. Johansen JA, Yu Z, Mo K, Monks DA, Lieberman AP, et al. (2008) Recovery of function in a myogenic mouse model of spinal bulbar muscular atrophy. Neurobiol Dis.
58. Yu Z, Dadgar N, Albertelli M, Scheller A, Albin RL, et al. (2006) Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant protein. Am J Pathol 168: 195-204.
59. Katsuno M, Adachi H, Kume A, Li M, Nakagomi Y, et al. (2002) Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35: 843-854.
60. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868.
61. Ramakers C, Ruijter JM, Deprez RH, Moorman AF (2003) Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 339: 62-66.
62. Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386.